Lipopolysaccharide removal affinity matrices based on novel cationic amphiphilic peptides

Mina Sepahi1, Shahin Hadadian1, Reza Ahangari Cohan1

  • 1Nano-Biotechnology Department, New Technologies Research Group, Pasteur Institute of Iran, Tehran, Iran.

Summary

Newly designed cationic amphiphilic peptides (CAPs) effectively remove lipopolysaccharide (LPS) contaminants from biopharmaceuticals. Immobilized S3E3 peptide demonstrated superior LPS removal efficiency compared to S3E3A, optimizing bioprocess purification.